openPR Logo
Press release

Rabeprazole Sodium Market Research Report

07-19-2023 04:51 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

Rabeprazole Sodium is a proton pump inhibitor (PPI) to reduce stomach acid and is used for the treatment of gastroesophageal reflux disease (GERD), duodenal ulcers, and used in combination with antibiotics to treat Helicobacter pylori bacterial infections in the stomach.

The global Rabeprazole Sodium market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Rabeprazole Sodium is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Rabeprazole Sodium is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Rabeprazole Sodium include JSN Chemicals, Jubilant Pharma, Smaart Pharmaceutticals, Shanghai Pharma Group Changzhou Kony Pharmaceutical, ASN Corporation, Intas, Sterile India, Zhejiang Yongtai Technology and Enal Drugs Private Limited, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Full Report Link:
https://reports.valuates.com/market-reports/QYRE-Auto-38L3723/global-rabeprazole-sodium

Enquire for Free Sample:
https://reports.valuates.com/request/sample/QYRE-Auto-38L3723/Global_Rabeprazole_Sodium_Market_Insights_and_Forecast_to_2028

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rabeprazole Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rabeprazole Sodium.

The Rabeprazole Sodium market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Rabeprazole Sodium market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Rabeprazole Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Key Segmentations

By Company
JSN Chemicals
Jubilant Pharma
Smaart Pharmaceutticals
Shanghai Pharma Group Changzhou Kony Pharmaceutical
ASN Corporation
Intas
Sterile India
Zhejiang Yongtai Technology
Enal Drugs Private Limited
Syntech Chem&Pharm

Segment by Type
Rabeprazole Sodium Monohydrate
Rabeprazole Sodium Crystalline

Segment by Application
Gastroesophageal Reflux Disease Treatment
Duodenal Ulcer Treatment
Others

Similar Reports:
https://reports.valuates.com/market-reports/QYRE-Auto-6R8542/global-ortho-phenylene-diamine-opd
https://reports.valuates.com/market-reports/QYRE-Auto-15W8362/global-1-2-phenylenediamine
https://reports.valuates.com/market-reports/QYRE-Auto-14W8322/global-1-2-diaminobenzene

Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137

Email Id:
Please reach us at sales@valuates.com

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rabeprazole Sodium Market Research Report here

News-ID: 3138008 • Views:

More Releases from Valuates Reports

DUV Lithography Machine Market Share Driven by Semiconductor Advancements and Ch …
DUV Lithography Machine Market Size The global market for DUV Lithography Machine was valued at US$ 15440 million in the year 2024 and is projected to reach a revised size of US$ 22840 million by 2031, growing at a CAGR of 5.8% during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-10P7860/Global_DUV_Lithography_Machine_Market_Insights_and_Forecast_to_2028 The DUV lithography machine market is expanding rapidly as the global semiconductor industry pushes toward higher performance and advanced manufacturing. Market growth is being
FTTx Junction Box Market Share Driven by Fiber Network Expansion and Rising Conn …
FTTx Junction Box Market The global market for FTTx Junction Box was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-30Z12110/Global_FTTx_Junction_Box_Market_Research_Report_2022 The FTTx junction box market is witnessing strong growth as global demand for high-speed internet and reliable digital infrastructure continues to rise. Market trends highlight significant investments in
Virtual Reality (VR) and Augmented Reality (AR) Microdisplay Market Share Driven …
Virtual Reality (VR) and Augmented Reality (AR) Microdisplay Market The global market for Virtual Reality (VR) and Augmented Reality (AR) Microdisplay was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-0L12932/Global_Virtual_Reality_VR_and_Augmented_Reality_AR_Microdisplay_Market_Research_Report_2022 The virtual reality (VR) and augmented reality (AR) microdisplay market is gaining significant momentum as immersive technologies transform
NCA Battery Market Share Driven by Rising Demand for Electric Mobility and Energ …
NCA Battery (Lithium Nickel Cobalt Aluminum Oxide Battery) Market Lithium nickel cobalt aluminum oxide batteries are also called NCA batteries, and are becoming increasingly important in electric powertrains and in grid storage. NCA batteries are not common in the consumer industry, but are promising for the automotive industry. NCA batteries provide a high-energy option with a good lifespan, but they are not as safe as they could be and are quite

All 5 Releases


More Releases for Rabeprazole

Rabeprazole Sodium Market Analysis Current Landscape and Future Outlook
The global Rabeprazole Sodium market was valued at approximately USD 681.2 million in 2024 and is projected to reach around USD 920 million by 2033, growing at a compound annual growth rate (CAGR) of about 3.5% from 2025 to 2033. Rabeprazole Sodium Market Overview The Rabeprazole Sodium market is driven by the rising prevalence of gastrointestinal disorders such as GERD, peptic ulcers, and Zollinger-Ellison syndrome, which are increasingly common due to changing
Rabeprazole Sodium Market Size, Growth Drivers, and Competitive Landscape.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Rabeprazole Sodium Market Size, Share & Trends Analysis Report By Application (Gastroesophageal Reflux Disease, Peptic Ulcer, Others), By Age (Below 55 Years, Above 55 Years), By Distribution Channel (Hospital Pharmacies, Drug And Retail Store Pharmacies, Online Providers)- Market Outlook And Industry Analysis 2031" The global rabeprazole sodium market is estimated to reach over USD 923.72
Rabeprazole Sodium Market: Size, Share, Growth, Analysis, Key Players, Revenue, …
Rabeprazole Sodium Market Rabeprazole Sodium is a proton pump inhibitor (PPI) to reduce stomach acid and is used for the treatment of gastroesophageal reflux disease (GERD), duodenal ulcers, and used in combination with antibiotics to treat Helicobacter pylori bacterial infections in the stomach. The global Rabeprazole Sodium market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast
Rabeprazole Sodium Market Size Estimated to Observe Significant Growth by 2031
The Rabeprazole Sodium Market is a significant segment within the pharmaceutical industry, specializing in medications containing rabeprazole sodium, a proton pump inhibitor (PPI) commonly prescribed to manage acid-related gastrointestinal conditions. Rabeprazole sodium is used in the treatment of disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. This market has experienced steady growth due to the increasing prevalence of acid-related disorders and the effectiveness of rabeprazole sodium
Rabeprazole Sodium Market expected to Witness Huge Revenue Growth to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Rabeprazole Sodium Market Size, Share & Trends Analysis Report By Application (Gastroesophageal Reflux Disease, Peptic Ulcer, Others), By Age (Below 55 Years, Above 55 Years), By Distribution Channel (Hospital Pharmacies, Drug And Retail Store Pharmacies, Online Providers)- Market Outlook And Industry Analysis 2031". The Global Rabeprazole Sodium Market Size is valued at 640.89 million in 2022
Rabeprazole Sodium Market Research Report
Rabeprazole Sodium is a proton pump inhibitor (PPI) to reduce stomach acid and is used for the treatment of gastroesophageal reflux disease (GERD), duodenal ulcers, and used in combination with antibiotics to treat Helicobacter pylori bacterial infections in the stomach. The global Rabeprazole Sodium market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029.